Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1985 1
1998 1
1999 2
2000 1
2003 1
2004 5
2005 2
2006 3
2007 4
2008 4
2009 4
2010 5
2011 7
2012 9
2013 8
2014 3
2015 5
2016 4
2017 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.
Aghajanian C, Blank SV, Goff BA, Judson PL, Teneriello MG, Husain A, Sovak MA, Yi J, Nycum LR. Aghajanian C, et al. Among authors: judson pl. J Clin Oncol. 2012 Jun 10;30(17):2039-45. doi: 10.1200/JCO.2012.42.0505. Epub 2012 Apr 23. J Clin Oncol. 2012. PMID: 22529265 Free PMC article. Clinical Trial.
Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment.
Akce M, El-Khoueiry A, Piha-Paul SA, Bacque E, Pan P, Zhang ZY, Ewesuedo R, Gupta D, Tang Y, Milton A, Zajic S, Judson PL, O'Bryant CL. Akce M, et al. Among authors: judson pl. Cancer Chemother Pharmacol. 2021 Nov;88(5):825-836. doi: 10.1007/s00280-021-04329-8. Epub 2021 Jul 29. Cancer Chemother Pharmacol. 2021. PMID: 34324028 Free PMC article. Clinical Trial.
Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance.
Boac BM, Xiong Y, Marchion DC, Abbasi F, Bush SH, Ramirez IJ, Khulpateea BR, Clair McClung E, Berry AL, Bou Zgheib N, Chon HS, Shahzad MM, Judson PL, Wenham RM, Apte SM, Berglund AE, Magliocco AM, Lancaster JM. Boac BM, et al. Among authors: judson pl. Gynecol Oncol. 2016 Feb;140(2):259-63. doi: 10.1016/j.ygyno.2015.12.026. Epub 2015 Dec 28. Gynecol Oncol. 2016. PMID: 26731723 Free PMC article.
BAD-mediated apoptotic pathway is associated with human cancer development.
Stickles XB, Marchion DC, Bicaku E, Al Sawah E, Abbasi F, Xiong Y, Bou Zgheib N, Boac BM, Orr BC, Judson PL, Berry A, Hakam A, Wenham RM, Apte SM, Berglund AE, Lancaster JM. Stickles XB, et al. Among authors: judson pl. Int J Mol Med. 2015 Apr;35(4):1081-7. doi: 10.3892/ijmm.2015.2091. Epub 2015 Feb 5. Int J Mol Med. 2015. PMID: 25653146 Free PMC article.
Hysteroscopy and cytology in endometrial cancer.
Bradley WH, Boente MP, Brooker D, Argenta PA, Downs LS, Judson PL, Carson LF. Bradley WH, et al. Among authors: judson pl. Obstet Gynecol. 2004 Nov;104(5 Pt 1):1030-3. doi: 10.1097/01.AOG.0000143263.19732.18. Obstet Gynecol. 2004. PMID: 15516397
Vaginal adenosarcoma arising from endometriosis.
Judson PL, Temple AM, Fowler WC Jr, Novotny DB, Funkhouser WK Jr. Judson PL, et al. Gynecol Oncol. 2000 Jan;76(1):123-5. doi: 10.1006/gyno.1999.5617. Gynecol Oncol. 2000. PMID: 10620454
BAD phosphorylation determines ovarian cancer chemosensitivity and patient survival.
Marchion DC, Cottrill HM, Xiong Y, Chen N, Bicaku E, Fulp WJ, Bansal N, Chon HS, Stickles XB, Kamath SG, Hakam A, Li L, Su D, Moreno C, Judson PL, Berchuck A, Wenham RM, Apte SM, Gonzalez-Bosquet J, Bloom GC, Eschrich SA, Sebti S, Chen DT, Lancaster JM. Marchion DC, et al. Among authors: judson pl. Clin Cancer Res. 2011 Oct 1;17(19):6356-66. doi: 10.1158/1078-0432.CCR-11-0735. Epub 2011 Aug 17. Clin Cancer Res. 2011. PMID: 21849418 Free PMC article.
62 results